[1]Patent:US5624935,1997,A
1048913-13-8
1048913-05-8
1613719-78-0 | 2-Amino-4-bromo-5-trifluoromethyl-phenol | AA00ASW3 | MFCD28741410
30041-95-3 | Ethyl 2-(4-cyanophenoxy)acetate | AA00BEW6 | MFCD01672078
3967-57-5 | ETHYL HYDROCAFFEATE | AA00BXD0 | MFCD00002207
401566-80-1 | (2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-(3-thiazolidinylcarbonyl)-1-pyrrolidinecarboxylic acid tert-butyl ester | AA00C69S | MFCD22665916
38418-25-6 | N-(4-Iodophenyl)-3-oxobutanamide | AA00CJ01 | MFCD00053248
4219-46-9 | 2-hydroxyethyl butyrate | AA00CYN8 | MFCD28360989
474-87-3 | ,9-Dehydroestrone | AA00DF7M | MFCD00271654
475563-22-5 | (+/-)-((exo, RS), RS) Biperiden Hydrochloride | AA00DOVU
568-76-3 | gamma-hydroxyphenylbutazone | AA00EF7O | MFCD01693333
6008-91-9 | [(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[hydroxy-[hydroxy-[3-hydroxy-2,2-dimethyl-3-[2-[2-(2-methylprop-2-enoylsulfanyl)ethylcarbamoyl]ethylcarbamoyl]propoxy]phosphoryl]oxy-phosphoryl]oxymethyl]oxolan-3-yl]oxyphosphonic acid | AA00F328
